NEWS CENTER

To seize the opportunities for opening-up and development, and to leverage financial resources to broaden the path for international development, the "Cross-Border Financial Services for Hubei's High-Level Opening-Up and Empowering Hubei Enterprises in 'Going Global' – Governm

——Reed Biotech Attends the Optics Valley Bio-Pharmaceutical Customs Policy Briefing To help biopharmaceutical companies reduce costs and increase efficiency, accelerate R&D, and streamline import/export customs clearance, and to precisely unlock industry-specific policy benefits,

Tired of repeatedly crunching numbers after protein quantification with ELISA? We’ve got a handy new feature for you: Reed Biotech official website now has a brand-new Online Calculation Tool! This tool is custom-developed based on our company's product types, parameters, etc. The data standards

As the global scientific community strives to accelerate discovery while reducing environmental impact, sustainability is no longer a future goal—it is a responsibility we must embrace today. At Reed Biotech, we believe that cutting-edge research should not come at the expense of the planet. Tha

——Our Company Participates in the 2026 Central Asia Market Expansion Forum for Private Enterprises To seize new opportunities arising from China's continued opening-up strategy and support private enterprises in expanding into overseas markets, the 2026 Central Asia Market Expansion Forum for

As the classic gold standard for quantitative biomarker detection, the three-step sandwich ELISA — leveraging the biotin-streptavidin (BAS) system and its multi-level signal amplification capability — has long been the mainstream solution in research and in vitro diagnostics. It is widely applied to